Bright Minds Biosciences Inc. (DRUG) stock
DRUGNasdaqPharmaceutical PreparationsFiscal year ends September 30
$20.76+0.25 (+1.22%)
Close on Nov 18, 2026Market cap $158.52MP/E –Yield –
Bright Minds Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bright Minds Biosciences's enterprise value was $102.51M on Nov 11, 2026, against $242.38M a year earlier. Over the last 5 years it ranged from -$8.18M to $545.60M, with a median of $2.99M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $102.51M | -78.5% |
| 2025 | Dec 31, 2025 | $476.30M | +214.8% |
| 2024 | Dec 31, 2024 | $151.28M | +72651.0% |
| 2023 | Dec 29, 2023 | $207.94K | -62.0% |
| 2022 | Dec 30, 2022 | $547.52K | -95.8% |
| 2021 | Dec 31, 2021 | $12.98M | – |
See a number that looks wrong?